Exhaled Nitric Oxide Is Elevated in Patients With Progressive Systemic Sclerosis Without Interstitial Lung Disease

This publication has 17 references indexed in Scilit:

• Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force
  European Respiratory Journal, 1997
• Oxidants/antioxidants in idiopathic pulmonary fibrosis.
  Thorax, 1995
• Nasaily exhaled nitric oxide in humans originates mainly in the paranasal sinuses
  Acta Physiologica Scandinavica, 1994
• Multifunctional role of nitric oxide in inflammation
  Trends in Endocrinology & Metabolism, 1994
• Immunohistochemical localization of transforming growth factor‐β₁ in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders
  Histopathology, 1994
• Nitric oxide and lung disease.
  Thorax, 1993
• Cytokines and pulmonary fibrosis.
  Thorax, 1993
• Fibroblast growth factors in connective tissue disease associated interstitial lung disease
  Clinical and Experimental Immunology, 1992
• Evaluation and management of scleroderma lung disease using bronchoalveolar lavage
  The American Journal of Medicine, 1990
• STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
  The Lancet, 1986